Premium
Private equity investors Blackstone and Advent International are in separate talks with the promoters of Suven Pharmaceuticals Ltd to buy a controlling stake, two people aware of the development said. “The sale process has been going on for a few months, and now Blackstone and Advent are in the final round ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
